Clinical Trial Update: Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the safety, pharmacodynamics, and pharmacokinetics of repeat dosing of GSK2136525 in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GSK2136525

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: TERMINATED